PRME icon

Prime Medicine
PRME

Upgrade to unlock
Buy
Hold
Sell

2 Wall Street Analysts provided 1 year price targets over the past 3 months

Low target
Avg. target
$6.63
101% upside
High target

2 analyst ratings

positive
1  neutral
50%
negative
Analyst & Firm Rating Price Target Upside
Downside 		Date
Citigroup
Citigroup
Samantha Semenkow
11 Nov ‘25 21 days ago
Chardan Capital
Chardan Capital
Geulah Livshits
40% 1-yr PRME win rate
10 Nov ‘25 22 days ago